 1. Patients are included, if they fulfill at least one of the following criteria defining refractory or relapsed AML according to previously established criteria 1-3: 1 Primary induction failure PIF after 2 cycles of chemotherapy. 2 First relapse. 3 Relapse refractory to salvage chemotherapy 4 Second or subsequent relapse. 